Glial fibrillary acidic protein (GFAP) is a protein that is encoded by the GFAP gene in humans. [5] It is a type III intermediate filament (IF) protein that is expressed by numerous cell types of the central nervous system (CNS), including astrocytes [6] and ependymal cells during development. [7]

Glial fibrillary acidic protein (GFAP) is an intermediate filament structural protein involved in cytoskeleton assembly and integrity, expressed in high abundance in activated glial cells. GFAP is neuroprotective, as knockout mice are hypersensitive to traumatic brain injury.

Glial fibrillary acidic protein (GFAP) is an intermediate filament (IF) III protein uniquely found in astrocytes in the central nervous system (CNS), non-myelinating Schwann cells in the peripheral nervous system (PNS), and enteric glial cells.

Glial fibrillary acidic protein (GFAP) is the major intermediate filament protein in astrocytes, one of the most abundant cell types in the vertebrate central nervous system (CNS). Transcriptional regulation of GFAP is of interest because of its astrocyte-specificity and its …

Glial fibrillary acidic protein (GFAP) is the major intermediate filament (IF) protein in astrocytes. In the human brain, GFAP isoforms have unique expression patterns, which indicate that they play distinct functional roles.

Glial fibrillary acidic protein (GFAP), a type III intermediate filament, is a marker of mature astrocytes. The expression of GFAP gene is regulated by many transcription factors (TFs), mainly Janus kinase-2/signal transducer and activator of transcription 3 cascade and nuclear factor κ …

Mar 12, 2020 · Using genetic fate-tracing, herein, we demonstrate for the first time that GFAP (glial fibrillary acidic protein)-positive progenitor cells are an important cell source for both vascular smooth muscle cells and endothelial cells in the mouse vasculature.

Glial Fibrillary Acidic Protein (GFAP) is a major protein found in the astrocytic cells of the brain, and it is considered a marker of astrogliosis, which is a characteristic feature of multiple sclerosis (MS) lesions.

Nov 7, 2024 · Glial fibrillary acidic protein (GFAP), a type III intermediate filament protein predominantly expressed in astrocytes, has emerged as a key biomarker for monitoring this response. During astrogliosis, GFAP is released into biofluids, making it a candidate for non-invasive diagnosis and tracking of neurodegenerative diseases.

May 15, 2018 · GFAP is responsible for the cytoarchitecture and mechanical strength of astrocytes and their supporting functions on the physiology of neighboring neurons and maintenance of blood–brain barrier. GFAP is involved in the pathophysiology of several neurologic disorders.